Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Stock Forecast

Stock Price Forecast

According to 15 professional analysts, the 12-month price target for Travere Therapeutics stock ranges from a low of $20 to a high of $47. The average analyst price target of $33.4 forecasts a 85.04% increase in the stock price over the next year.

Price Target: $33.40 (+85.04%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$33.4	$31	$47
Change	+10.80%	+85.04%	+71.75%	+160.39%

Analyst Ratings

The average analyst rating for Travere Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	5	5	5	5	6	6
Buy	8	8	8	8	8	8
Hold	1	1	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	15	15	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Greg Harrison Scotiabank	Scotiabank	Buy Maintains $30 → $31	Buy	Maintains	$30 → $31	+71.75%	Aug 7, 2025
Laura Chico Wedbush	Wedbush	Buy Maintains $30 → $32	Buy	Maintains	$30 → $32	+77.29%	Aug 7, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $30	Strong Buy	Initiates	$30	+66.20%	Jul 1, 2025
Carly Kenselaar Citigroup	Citigroup	Strong Buy Maintains $35 → $32	Strong Buy	Maintains	$35 → $32	+77.29%	Jun 11, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $30	Strong Buy	Initiates	$30	+66.20%	Jun 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

400.16M

Increased by 71.61%

from 233.18M

Revenue Next Year

574.03M

Increased by 43.45%

from 400.16M

EPS This Year

-1.11

from -4.08

EPS Next Year

0.45

from -1.11

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	198.32M	131.84M	109.46M	145.24M	233.18M	400.16M	574.03M	758.16M
Revenue Growth	13.11%	-33.52%	-16.97%	32.69%	60.55%	71.61%	43.45%	32.08%
EPS	-3.56	-3.01	-4.37	-1.50	-4.08	-1.11	0.45	2.33
EPS Growth	-	-	-	-	-	-	-	422.12%
Forward PE	-	-	-	-	-	-	40.49	7.76
No. Analysts	-	-	-	-	-	17	17	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	466.6M	835.7M	1.2B
Avg	400.2M	574.0M	758.2M
Low	327.2M	441.2M	578.2M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	100.1%	108.8%	106.3%
Avg	71.6%	43.5%	32.1%
Low	40.3%	10.3%	0.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.53	3.37	6.29
Avg	-1.11	0.45	2.33
Low	-1.99	-1.20	0.25

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	1,311.0%
Avg	-	-	422.1%
Low	-	-	-45.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.